| Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience AJM Ferreri, JY Blay, M Reni, F Pasini, M Spina, A Ambrosetti, ... Journal of clinical oncology 21 (2), 266-272, 2003 | 909 | 2003 |
| Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study A Gallamini, C Stelitano, R Calvi, M Bellei, D Mattei, U Vitolo, F Morabito, ... Blood 103 (7), 2474-2479, 2004 | 766 | 2004 |
| Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue E Zucca, A Conconi, E Pedrinis, S Cortelazzo, T Motta, ... Blood, The Journal of the American Society of Hematology 101 (7), 2489-2495, 2003 | 635 | 2003 |
| Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type A Conconi, G Martinelli, C Thiéblemont, AJM Ferreri, L Devizzi, ... Blood 102 (8), 2741-2745, 2003 | 481 | 2003 |
| Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group G Ryan, G Martinelli, M Kuper-Hommel, R Tsang, G Pruneri, K Yuen, ... Annals of Oncology 19 (2), 233-241, 2008 | 327 | 2008 |
| Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion M Magni, M Di Nicola, L Devizzi, P Matteucci, F Lombardi, L Gandola, ... Blood, The Journal of the American Society of Hematology 96 (3), 864-869, 2000 | 306 | 2000 |
| Gemcitabine in the treatment of refractory Hodgkin’s disease: results of a multicenter phase II study A Santoro, H Bredenfeld, L Devizzi, H Tesch, V Bonfante, S Viviani, ... Journal of Clinical Oncology 18 (13), 2615-2619, 2000 | 296 | 2000 |
| Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD. V Bonfante, A Santoro, S Viviani, L Devizzi, M Balzarotti, F Soncini, ... Journal of Clinical Oncology 15 (2), 528-534, 1997 | 262 | 1997 |
| Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients PL Zinzani, M Martelli, M Bertini, AM Gianni, L Devizzi, M Federico, ... haematologica 87 (12), 1258-1264, 2002 | 243 | 2002 |
| Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results. S Viviani, G Bonadonna, A Santoro, V Bonfante, M Zanini, L Devizzi, ... Journal of Clinical Oncology 14 (5), 1421-1430, 1996 | 234 | 1996 |
| Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: improved event-free and progression-free survival with rituximab plus chlorambucil … E Zucca, A Conconi, G Martinelli, R Bouabdallah, A Tucci, U Vitolo, ... J Clin Oncol 35 (17), 1905-1912, 2017 | 172 | 2017 |
| Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a … M Di Nicola, R Zappasodi, C Carlo-Stella, R Mortarini, SM Pupa, M Magni, ... Blood, The Journal of the American Society of Hematology 113 (1), 18-27, 2009 | 155 | 2009 |
| Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease L Devizzi, A Santoro, V Bonfante, S Viviani, L Balzarini, P Valagussa, ... Annals of Oncology 5 (9), 817-820, 1994 | 101 | 1994 |
| Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple … C Tarella, M Zanni, M Di Nicola, C Patti, R Calvi, A Pescarollo, V Zoli, ... Leukemia 21 (8), 1802-1811, 2007 | 98 | 2007 |
| High-dose yttrium-90–ibritumomab tiuxetan with tandem stem-cell reinfusion: An outpatient preparative regimen for autologous hematopoietic cell transplantation L Devizzi, A Guidetti, C Tarella, M Magni, P Matteucci, E Seregni, ... Journal of clinical oncology 26 (32), 5175-5182, 2008 | 88 | 2008 |
| Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG) A Conconi, G Martinelli, A Lopez-Guillermo, PL Zinzani, AJM Ferreri, ... Annals of oncology 22 (3), 689-695, 2011 | 78 | 2011 |
| Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease L Devizzi, L Maffioli, V Bonfante, S Viviani, L Balzarini, M Gasparini, ... Annals of oncology 8, S53-S56, 1997 | 75 | 1997 |
| The lymphocyte to monocyte ratio improves the IPI‐risk definition of diffuse large B‐cell lymphoma when rituximab is added to chemotherapy A Rambaldi, C Boschini, G Gritti, F Delaini, E Oldani, A Rossi, AM Barbui, ... American journal of hematology 88 (12), 1062-1067, 2013 | 71 | 2013 |
| Intergruppo Italiano Linfomi. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study A Gallamini, C Stelitano, R Calvi, M Bellei, D Mattei, U Vitolo, F Morabito, ... Blood 103 (7), 2474-2479, 2004 | 68 | 2004 |
| Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: results of a multicenter phase 2 trial AJM Ferreri, S Govi, M Raderer, A Mulè, A Andriani, D Caracciolo, ... Blood, The Journal of the American Society of Hematology 120 (18), 3858-3860, 2012 | 64 | 2012 |
